Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Zhejiang Jiuzhou Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
132
314
671
266
411
306
Total Accounts Receivable
165
337
287
423
367
641
Inventories
363
474
573
458
542
535
Other Current Assets
42
39
11
13
16
24
Total Current Assets
702
1,164
1,542
1,161
1,337
1,506
Net Property, Plant & Equipment
753
960
1,578
1,604
1,534
1,522
Total Investments and Advances
26
26
7
20
21
22
Long-Term Note Receivable
-
-
-
-
25
21
Intangible Assets
68
55
129
161
214
200
Other Assets
-
-
76
48
7
24
Total Assets
1,551
2,208
3,335
2,999
3,143
3,305
ST Debt & Current Portion LT Debt
488
309
429
81
144
Accounts Payable
146
222
249
247
183
Income Tax Payable
11
4
4
4
8
Other Current Liabilities
50
45
61
66
73
Total Current Liabilities
694
579
743
398
408
Long-Term Debt
79
10
48
3
-
Deferred Taxes
-
3
4
5
4
Other Liabilities
38
-
-
-
-
Total Liabilities
814
589
792
401
408
Common Equity (Total)
733
1,576
2,511
2,556
2,675
Total Shareholders' Equity
733
1,576
2,511
2,556
2,675
Total Equity
737
1,579
2,511
2,562
2,681
Liabilities & Shareholders' Equity
1,551
2,208
3,335
2,999
3,143
Accumulated Minority Interest
4
2
-
7
6
Non-Equity Reserves
-
41
32
35
54

About Zhejiang Jiuzhou Pharmaceutical Co.

View Profile
Address
99 Waisha Road
Taizhou Zhejiang 318000
China
Employees -
Website http://www.jiuzhoupharma.com
Updated 07/08/2019
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua in 1973 and is headquartered in Taizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.